JPRN-UMIN000000727已完成2 期
Phase II study of a combination of modified CPT-11 and 5-FU/l-LV (mJIFL) in patients with meatastatic colorectal cancer - OGSG 0601
OGSG0 个研究点目标入组 54 人开始时间: 2007年6月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. with interstitial pneumonitis or pulmonary fibrosis 2. cavity fluid which should be taken out 3. with double cancer and/or multiple cancer which excludes carcinoma in situ 4. with infectious disease, intestinal paralysis, or intestinal obstraction 5. under the condition of diarrhea (watery diarrhea) 6. under insulin therapy or uncontrolled DM 7. with ulcer on digestive organs 8. with ischemic cardiac disease 9. with psychological disorder which disturb the entry to the study 10. under HBs-Antigen(+), HCV antibody(+), or HIV antibody(+) 11. under continuous steroids therapy 12. with other severe diseases(cardiac failure, liver dysfunction, or renal dysfunction) 13. brain metastasis with some symptoms 14. pregnant and/or nursing women 15. with allergic history against medicines 16. doctors' stop not to register to the study
研究者
相似试验
已完成
不适用
Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancerPreviously untreated stageIIIB/IV NSCLCJPRN-C000000415West Japan Oncology Group55
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and Panitumumab in patients with KRAS wild-type metastatic colon cancer.KRAS wild-type metastatic colon cancer.JPRN-UMIN000005368iigata Colorectal cancer Chemotherapy Study Group (NCCSG)25
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer.metastatic colorectal cancerJPRN-UMIN000001631iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
招募中
不适用
Randomized phase II study of CPT-11 plus TS-1 plus Cetuximab for advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild type (OGSG 0901)advanced and/or recurrent colon cancer which are oxaliplatin-resistant and KRAS wild typeJPRN-UMIN000002695Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)35
未知
1 期
Phase1study of a combination of CPT-11 and TS-1 and bevacizumab in patients with metastatic colon cancermetastatic colorectal cancerJPRN-UMIN000001219Department of Surgery, Suita Municipal Hospital24